NamrataSoniaChandhokMD

PubMed

• 10 citations
  Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape.
  Prajwal C Boddu, Abhishek K Gupta, Rahul Roy, Bárbara De La Peña Avalos, Anne Olazabal-Herrero
  Molecular Cell. 2024-04-18
• 4 citations
  Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients.
  Akshay M Khatri, Yoichiro Natori, Anthony Anderson, Ra'ed Jabr, Shreya A Shah
  Transplant Infectious Disease. 2023-11-01
• 488 citations
  Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes
  Mijung Kwon, Susana A. Godinho, Namrata S. Chandhok, Neil J. Ganem, Ammar Azioune
  Genes & Development. 2008-08-15

Abstracts/Posters

• PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors
  Namrata S Chandhok, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. a Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Mye... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Ivo-Nivo: A Phase II Study of the IDH1 Inhibitor Ivosidenib (AG-120) in Combination with the Checkpoint Blockade Inhibitor Nivolumab for Patients with IDH1 Mutated Rel... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Peripheral Blood Involvement By Flow Cytometry As a Prognostic Factor in Aggressive T Cell Lymphomas Following Autologous Stem Cell Transplantation 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019